Inventor · disambiguated record
Ruoxi Lan
Also filed as: LAN RUOXI
37 granted patents·5 pending applications·177 citations·filing 2000–2020
97Inventor score
Top patents by PatentIndex Score
42 records- 0196US9969710B2Heteroaryl compounds as IRAK inhibitors and uses thereofMERCK PATENT GMBH·Filed 2016·Granted May 15, 2018·41 cites·20 claims
- 0291US10836750B1TLR7/8 antagonists and uses thereofMERCK PATENT GMBH·Filed 2020·Granted Nov 17, 2020·2 cites·17 claims
- 0389US9815836B2Macrocyclic compounds as IRAK1/4 inhibitors and uses thereofMERCK PATENT GMBH·Filed 2017·Granted Nov 14, 2017·7 cites·20 claims
- 0489US9624246B2Pyridazinone macrocycles as IRAK inhibitors and uses thereofMERCK PATENT GMBH·Filed 2016·Granted Apr 18, 2017·8 cites·14 claims
- 0588US9708324B2Macrocyclic compounds as IRAK1/4 inhibitors and uses thereofMERCK PATENT GMBH·Filed 2016·Granted Jul 18, 2017·7 cites·25 claims
- 0687US8008440B2Combinatorial synthesis of libraries of macrocyclic compounds useful in drug discoveryTRANZYME PHARMA INC·Filed 2006·Granted Aug 30, 2011·8 cites·2 claims
- 0787US7169899B1Combinatorial synthesis of libraries of macrocyclic compounds useful in drug discoveryTRANZYME PHARMA INC·Filed 2000·Granted Jan 30, 2007·23 cites·3 claims
- 0885US7452862B2Conformationally-controlled biologically active macrocyclic small molecules as motilin antagonists or ghrelin agonistsTRANZYME PHARMA INC·Filed 2004·Granted Nov 18, 2008·23 cites·4 claims
- 0984US10793553B2TLR7/8 antagonists and uses thereofMERCK PATENT GMBH·Filed 2018·Granted Oct 6, 2020·2 cites·17 claims
- 1083US9580443B2Heterocyclic derivatives as modulators of kinase activityMERCK PATENT GMBH·Filed 2013·Granted Feb 28, 2017·5 cites·14 claims
- 1183US8569295B2Bicyclic urea compoundsCHEN XIAOLING·Filed 2010·Granted Oct 29, 2013·8 cites·60 claims
- 1282US9440968B2Substituted pyrido[3,2-d]pyrimidines for treating cancerMERCK PATENT GMBH·Filed 2013·Granted Sep 13, 2016·5 cites·14 claims
- 1382US8637532B2Amino azaheterocyclic carboxamidesSUTTON AMANDA E·Filed 2010·Granted Jan 28, 2014·9 cites·10 claims
- 1480US9139568B2Heterocyclic carboxamides as modulators of kinase activityMERCK PATENT GMBH·Filed 2012·Granted Sep 22, 2015·4 cites·13 claims
- 1580US8022252B2Spatially-defined macrocyclic compounds useful for drug discoveryTRANZYME PHARMA INC·Filed 2008·Granted Sep 20, 2011·4 cites·3 claims
- 1679US10517872B2Pyridazinone macrocycles as IRAK inhibitors and uses thereofMERCK PATENT GMBH·Filed 2017·Granted Dec 31, 2019·2 cites·16 claims
- 1779US9145392B2Imidazole amines as modulators of kinase activityLAN RUOXI·Filed 2012·Granted Sep 29, 2015·6 cites·26 claims
- 1878US9458134B2Heterocycles as modulators of kinase activityMERCK PATENT GMBH·Filed 2014·Granted Oct 4, 2016·3 cites·18 claims
- 1976US9321760B2Aminopyrimidine derivatives for use as modulators of kinase activityLAN RUOXI·Filed 2012·Granted Apr 26, 2016·3 cites·17 claims
- 2075US10080750B2Aminopyrimidine derivatives for use as modulators of kinase activityMERCK PATENT GMBH·Filed 2017·Granted Sep 25, 2018·1 cites·10 claims
- 2174US9040560B2Amino azaheterocyclic carboxamidesMERCK PATENT GMBH·Filed 2013·Granted May 26, 2015·2 cites·9 claims
- 2272US9662330B2Aminopyrimidine derivatives for use as modulators of kinase activityMERCK PATENT GMBH·Filed 2016·Granted May 30, 2017·1 cites·15 claims
- 2370US9018419B2Combinatorial synthesis of libraries of macrocyclic compounds useful in drug discoveryDESLONGCHAMPS PIERRE·Filed 2011·Granted Apr 28, 2015·1 cites·2 claims
- 2466US8710044B2Bicyclic azaheterocyclic carboxamidesHUCK BAYARD R·Filed 2011·Granted Apr 29, 2014·1 cites·9 claims
- 2565US9434714B2Pyrimidine imidazole amines as modulators of kinase activityMERCK PATENT GMBH·Filed 2015·Granted Sep 6, 2016·1 cites·5 claims
- 2657US10287300B2Heterocyclic derivatives as modulators of kinase activityMERCK PATENT GMBH·Filed 2017·Granted May 14, 2019·0 cites·18 claims
- 2757US10233160B2Substituted pyrido[3,4-d]pyrimidines and pyrido[4,3-d]pyrimidines as p70S6K inhibitorsMERCK PATENT GMBH·Filed 2018·Granted Mar 19, 2019·0 cites·12 claims
- 2856US8188216B2Combinatorial synthesis of libraries of macrocyclic compounds useful in drug discoveryDESLONGCHAMPS PIERRE·Filed 2004·Granted May 29, 2012·0 cites·11 claims
- 2954US9409945B2Combinatorial synthesis of libraries of macrocyclic compounds useful in drug discoveryOCERA THERAPEUTICS INC·Filed 2015·Granted Aug 9, 2016·0 cites·3 claims
- 3053US9850255B2Heterocyclic derivatives as modulators of kinase activityMERCK PATENT GMBH·Filed 2016·Granted Dec 26, 2017·0 cites·12 claims
- 3152US10080753B2Heterocyclic carboxamides as modulators of kinase activityMERCK PATENT GMBH·Filed 2016·Granted Sep 25, 2018·0 cites·5 claims
- 3252US9981925B2Substituted benzo[d][1,2,3]triazines as p70S6K inhibitorsMERCK PATENT GMBH·Filed 2016·Granted May 29, 2018·0 cites·12 claims
- 3351US10392375B2Heteroaryl compounds as IRAK inhibitors and uses thereofMERCK PATENT GMBH·Filed 2018·Granted Aug 27, 2019·0 cites·11 claims
- 3450US2011282056A1Protein kinase inhibitors and use thereofASKEW BENNY C·Filed 2009·Application pending·0 cites
- 3549US2018237413A1Heteroaryl compounds as irak inhibitors and uses thereofMERCK PATENT GMBH·Filed 2018·Application pending·0 cites
- 3648US9867826B2Heterocycles as modulators of kinase activityMERCK PATENT GMBH·Filed 2016·Granted Jan 16, 2018·0 cites·12 claims
- 3747US2016058763A1Novel heterocyclic carboxamides as modulators of kinase activityMERCK PATENT GMBH·Filed 2015·Application pending·0 cites
- 3846US10059701B2Heteroaryl compounds as IRAK inhibitors and uses thereofMERCK PATENT GMBH·Filed 2016·Granted Aug 28, 2018·0 cites·11 claims
- 3945US9315517B2Imidazol-piperidinyl derivatives as modulators of kinase activityMERCK PATENT GMBH·Filed 2013·Granted Apr 19, 2016·0 cites·16 claims
- 4044US2021300940A1Tlr7/8 antagonists and uses thereofMERCK PATENT GMBH·Filed 2019·Application pending·0 cites
- 4141US2016000785A1Novel Imidazole Amines as Modulators of Kinase ActivityMERCK PATENT GMBH·Filed 2015·Application pending·0 cites
- 4232US9023847B2Azaheterocyclic compoundsSUTTON AMANDA E·Filed 2010·Granted May 5, 2015·0 cites·10 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →